Stay updated on Combining Rebastinib with Carboplatin in Advanced Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Combining Rebastinib with Carboplatin in Advanced Solid Tumors Clinical Trial page.

Latest updates to the Combining Rebastinib with Carboplatin in Advanced Solid Tumors Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe page now shows Revision: v3.4.2 instead of Revision: v3.4.1, indicating a minor version update to the site template.SummaryDifference0.0%

- Check19 days agoChange DetectedMinor update: the site revision label changed from v3.4.0 to v3.4.1, a non-significant change that does not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check41 days agoChange DetectedThe page revision label has been updated from v3.3.3 to v3.3.4.SummaryDifference0.0%

- Check63 days agoChange DetectedLocations section reorganized into a single 'Locations' list covering California, Illinois, Kansas, North Carolina, Ohio, Tennessee, and Texas, with the separate state location sections removed and the HHS Vulnerability Disclosure removed; revision updated to v3.3.3.SummaryDifference0.7%

- Check92 days agoChange DetectedRevision: v3.3.2 was added and v3.2.0 removed on the page. This appears to be a version update with no impact on the trial details visible on the page.SummaryDifference0.0%

- Check99 days agoChange DetectedThe visible site-wide notice about government funding and data currency was removed from the page. This banner is ancillary to the study details and does not affect the trial information presented.SummaryDifference0.3%

Stay in the know with updates to Combining Rebastinib with Carboplatin in Advanced Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Combining Rebastinib with Carboplatin in Advanced Solid Tumors Clinical Trial page.